LUNAR

Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide variety of diseases, including rare and orphan diseases